Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
LETTER TO THE EDITOR

Histiocytoid Sweet’s syndrome during combined therapy with BRAF and MEK inhibitors for metastatic melanoma

Morgado-Carrasco, Daniela; Moreno-Rivera, Nataliaa; Fustà-Novell, Xaviera; García-Herrera, Adrianab; Carrera, Cristinaa; Puig, Susanaa

Author Information
doi: 10.1097/CMR.0000000000000438
  • Buy
Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.